An official from the US Food and Drug Administration (FDA) on Monday presented three case studies demonstrating how sponsors effectively utilized real-world evidence (RWE) and real-world data (RWD) to ...

Patients who fasted during chemotherapy for ovarian cancer had significantly longer progression-free survival (PFS) compared ...

Resources for observational comparative research have expanded enormously in recent years to include very large sources of ...

A BC-led clinical research team is behind a study that could help improve care for critically ill patients in intensive care ...

Background Banning cigarette filter ventilation has been raised by some public health researchers and organisations because ...

Mehul V. Raval, MD, MS, discusses newly published findings from the ENRICH-US trial which evaluated the impact of a pediatric ...

Israeli Ministry of Health approved the initiation of Silexion's Phase 2/3 clinical trial of SIL204 in locally advanced ...

Adagene (NASDAQ:ADAG) Chief Strategy Officer Mickael Chane-Du outlined the company's clinical strategy for its lead antibody program, ADG126, during a discussion with Stifel senior biotech analyst ...

In patients with very high risk, high grade T1 with CIS NMIBC, the possible value of adding immune checkpoint blockade to BCG has not been defined.

Israeli Ministry of Health approved the initiation of Silexion's Phase 2/3 clinical trial of SIL204 in locally advanced pancreatic cancer Clinical Trial Application subsequently submitted to Germany ...

Background Hearing loss (HL) imposes a substantial burden on families and society and is the largest modifiable risk factor ...

Discusses Challenges in Breast Cancer Drug Development and Innovation in Clinical Research May 19, 2026 4:00 PM ...